Vaccine And Immune System The benefits of a vaccine produced by the human body itself have presumably increased in the health zone. Scientists from the Biotech Research and Innovation Centre (BRIC) at the University of Copenhagen suggest that the vaccine generated by human body enhances immune system and helps to keep chronic inflammatory diseases at bay. The research findings probably have greater significance for developing unique medications.

Researchers have laid hands on a protein that may normally prevent chronic tissue inflammation. If this protein is administered in the form of a therapeutic vaccine, it can possibly treat various inflammatory ailments such as multiple sclerosis (MS), rheumatoid arthritis (RA), skin hypersensitivity and allergic asthma (AA). The found vaccine apparently boosts special cells of the immune system, called as NKT cells. Known to be a type of T cell, NKT cells allegedly exert profound and diverse regulatory effects in disease, from autoimmunity to responses, pathogens and cancer.

Principal Investigator Shohreh Issazadeh-Navikas, group leader for Neuroinflammation Unit at BRIC and lead investigator, and colleagues claim that the ability of a self peptide to activate NKT cells for curbing various tissue-specific inflammatory conditions like experimental autoimmune diseases is extremely beneficial. The probable activation requirements and signaling pathway have also been identified. The findings reportedly help in treating several common conditions.

The research was published in the Journal of Clinical Investigation.